Related references
Note: Only part of the references are listed.World Health Organization Report: Current Crisis of Antibiotic Resistance
Amin Talebi Bezmin Abadi et al.
BIONANOSCIENCE (2019)
Multidrug-Resistant Acinetobacter baumannii: An Emerging Health Threat in Aseer Region, Kingdom of Saudi Arabia
Mohammed K. Almaghrabi et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2018)
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015
Sandra N. Bulens et al.
EMERGING INFECTIOUS DISEASES (2018)
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Li-Yang Hsu et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Antimicrobial susceptibility of Acinetobacter clinical isolates and emerging antibiogram trends for nosocomial infection management
Muhammad Sohail et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2016)
Multidrug-resistant bacterial isolates in infected wounds at Jimma University Specialized Hospital, Ethiopia
Girma Godebo et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Incidence of Acinetobacter Species Other than A. baumannii among Clinical Isolates of Acinetobacter: Evidence for Emerging Species
Jane F. Turton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
M. S. Oliveira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Multildrug-resistant Acinetobacter infection mortality rate and length of hospitalization
Rebecca H. Sunenshine et al.
EMERGING INFECTIOUS DISEASES (2007)
Share Paper
